Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(N-(4-(2-hydroxy-3-(1-(2-chlorophenyl)piperazinyl)propoxy)-3-methoxy)benzyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine MeSH Supplementary Concept Data 2025


MeSH Supplementary
(N-(4-(2-hydroxy-3-(1-(2-chlorophenyl)piperazinyl)propoxy)-3-methoxy)benzyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine
Unique ID
C505397
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C505397
Entry Term(s)
labedipinedilol C
labedipinedilol-C
Registry Numbers
0
Heading Mapped to
*Dihydropyridines
*Piperazines
Frequency
1
Note
a calcium channel antagonist; Receptors, Adrenergic, alpha-1 and beta-1 antagonist; structure in first source
Source
J Cardiovasc Pharmacol 2005 Aug;46(2):130-40
Date of Entry
2005/11/18
Revision Date
2009/11/13
(N-(4-(2-hydroxy-3-(1-(2-chlorophenyl)piperazinyl)propoxy)-3-methoxy)benzyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine Preferred
labedipinedilol C Narrower
page delivered in 0.002s